Quintiles Transnational Corp. signs  an agreement with Medca Japan to provide central laboratory services, further extending the Quintiles global network of laboratories certified by the College of American Pathologists (CAP).

Quintiles will have its own staff at the CAP-certified Medca Japan laboratory in Saitama, a city in the Greater Tokyo area. The lab will support clinical trials in Japan.

Yutaka Kannari, president of Medca Japan Laboratory Co., Ltd., said he was pleased that Medca has the capability and the high quality standards necessary to play an important role in the expansion of Quintiles' business in Asia, and he also sees the alliance helping Medca.

Medca provides a broad range of laboratory services, including biochemical tests as well as endocrine testing, tumour marker testing, drug-level testing, immunology testing and microbiological testing. The laboratory has undertaken specimens for examination from about 4,000 medical institutions throughout Japan.

CAP certification follows a site inspection. The accreditation is intended to improve patient safety by advancing the quality of pathology and laboratory services through education, setting standards and ensuring laboratories meet or exceed regulatory requirements.